Table 1.
1 | Bilateral hilar lymphadenopathy |
2 | Elevated serum angiotensin‐converting enzyme or lysozyme |
3 | Elevated soluble interleukin 2 receptor |
4 | Significant positive uptake on gallium citrate scintigraphy or 18F‐fluorodeoxyglucose positron emission tomography imaging |
5 | Increased CD4/CD8 ratio >3.5 in bronchoalveolar lavage fluid |
Consider as highly probable laboratory manifestations if ≥2 of 5 criteria have been met.